New gene therapy for the treatment of rare liver diseases
Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics focuses on optimising gene therapy by collaborating with the Foundation for Applied Medical Research (CIMA, University of Navarra) to develop novel liver-specific AAV vectors and generate new technologies to optimise gene delivery and long-term expression.
CEO: Bravo Eduardo.
80 Boulevard Haussmann,
75008 Paris, France.